PharmaSUG2020paper·US·Data StandardsImplementation of Immune Response Evaluation Criteria in Solid Tumors (iRECIST) in Efficacy Analysis of Oncology Studies DS-082See metadata
PharmaSUG2020paper·US·Data StandardsImpact of WHODrug B3/C3 Format on Coding of Concomitant Medications DS-109See metadata
PharmaSUG2020paper·US·Data StandardsCDISC-compliant Implementation of iRECIST and LYRIC for Immunomodulatory Therapy Trials DS-117See metadata
PharmaSUG2020paper·US·Data StandardsStandardizing Patient Reported Outcomes (PROs) DS-195See metadata
PharmaSUG2020paper·US·Data StandardsSimplifying PGx SDTM Domains for Molecular biology of Disease data (MBIO). DS-196See metadata
PharmaSUG2020paper·US·Data StandardsTackle Oncology Dose Intensity Analysis from EDC to ADaM DS-235See metadata
PharmaSUG2020paper·US·Data StandardsOvercoming Pitfalls of DS: Shackling ‘the Elephant in the room’ DS-329See metadata
PharmaSUG2020paper·US·Data StandardsCreating SDTMs and ADaMs CodeList Lookup Tables DS-365See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingLibrary Datasets Summary Macro %DATA_SPECS DV-004See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingWhat’s Your Favorite Color? Controlling the Appearance of a Graph DV-006See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingGreat Time to Learn GTL: A Step-by-Step Approach to Creating the Impossible DV-009See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingOncology Graphs-Creation (Using SAS and R), Interpretation and QA DV-050See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingR for Clinical Reporting, Yes – Let’s Explore it! DV-057See metadata
PharmaSUG2020paper·US·Data Visualization and ReportingSimplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies DV-066See metadata